openPR Logo
Press release

Kaposi's Sarcoma Treatment Market is Valued at USD 258.93 Million During the Forecast Period 2030

05-29-2023 07:41 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Kaposi's Sarcoma Treatment Market is Valued at USD 258.93

Kaposi's Sarcoma Treatment Market analysis report covers detailed value chain analysis of the market. The value chain analysis helps to analyze major upstream raw materials, major equipment's, manufacturing process, and downstream customer analysis and major distributor analysis are mentioned in the report along with all the drivers and restraints for the market. It presents a comparative detailed analysis of all regional and player segments, offering readers a better knowledge of the areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the market.

With the growing incidence of Kaposi Sarcoma and the increasing number of patients undergoing organ transplantation procedures, patients undergoing organ transplantations are more vulnerable to Kaposi sarcoma. Patients with weakened immune systems by acquired immune deficiency syndrome (AIDS) disease or drugs prescribed post-organ transplantation surgery are highly susceptible to HHV-8. Organ transplant patients are prescribed immunosuppressive agents to prevent their bodies from rejecting the graft, increasing their susceptibility to Kaposi sarcoma-associated herpesvirus (KSHV) infection. The long-term use of these agents surges these patients' risk rate by over 100 times more than the general population.

Data Bridge Market Research analyses a growth rate in the global Kaposi's sarcoma treatment market in the forecast period 2023-2020. The expected CAGR of the global Kaposi's sarcoma treatment market tends to be around 7.00% in the mentioned forecast period. The market was valued at USD 150.7 million in 2022 and would grow to USD 258.93 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Kaposi sarcoma is a type of malignant tumor disease majorly that is associated with skin, mucous membranes, lymph nodes, and other organs. These patches or lesions are generally red or purple. They are made of cancer cells, blood vessels, and blood cells. Human herpesvirus-8 (HHV-8) is predominantly found in the lesion of all patients suffering from Kaposi sarcoma.

Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/global-kaposis-sarcoma-treatment-market

Global Kaposi's Sarcoma Treatment Market Scope

The global Kaposi's sarcoma treatment market is segmented on the basis of type, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

Epidemic (AIDS Associated) Kaposi Sarcoma

Classic (Mediterranean) Kaposi Sarcoma

Endemic (African) Kaposi Sarcoma

Latrogenic (Transplant-Related) Kaposi Sarcoma)

Treatment

HAART

Radiation Therapy

Surgery

Cryosurgery

Chemotherapy

Biological Therapy

End-Users

Hospitals

Homecare

Speciality Centres

Others

Distribution Channel

Hospital Pharmacy

Online Pharmacy

Retail Pharmacy

Competitive Landscape and Global Kaposi's Sarcoma Treatment Market Share Analysis

The global Kaposi's sarcoma treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global Kaposi's sarcoma treatment market.

Key players operating in the global Kaposi's sarcoma treatment market include:

Johnson & Johnson Private Limited (U.S.)

Abbott (U.S.)

AbbVie Inc. (U.S.)

Bausch Health Companies Inc. (Canada)

Sun Pharmaceutical Industries Ltd. (India)

Aurobindo Pharma (India)

Lupin (India)

Hikma Pharmaceuticals PLC (U.K.)

Amneal Pharmaceuticals LLC. (U.S.)

Pfizer Inc (U.S.)

Mylan N.V. (U.S.)

Bristol-Myers Squibb Company (U.S.)

Bayer AG (Germany)

Browse Related Report:-

https://dbmr006.blogspot.com/2023/05/healthmedical-simulation-software.html

https://dbmr006.blogspot.com/2023/05/prion-disease-treatment-market-is-set.html

https://dbmr006.blogspot.com/2023/05/cover-slippers-market-is-estimated-to.html

https://dbmr006.blogspot.com/2023/05/cystoscope-market-size-was-valued-at.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Kaposi's Sarcoma Treatment Market is Valued at USD 258.93 Million During the Forecast Period 2030 here

News-ID: 3070585 • Views:

More Releases from Data Bridge Market Research

Fire Resistant Glass Market Advances with Intumescent Coatings, Hybrid Laminates & Prefab Curtainwalls, Driven by Stricter Codes, High‐Rise Growth & Multifunctional Glazing Innovations
Fire Resistant Glass Market Advances with Intumescent Coatings, Hybrid Laminates …
Fire resistant glass market is growing at a high CAGR during the forecast period 2024-2031. Fire Resistant Glass Market is positioned for robust growth, and shifting market dynamics reshaping the competitive landscape. DataM Intelligence's new report provides data-driven insights, SWOT analysis, and marketing-ready intelligence for businesses seeking to improve market penetration and campaign ROI. Get your exclusive sample report today: (corporate email gets priority access): https://datamintelligence.com/download-sample/fire-resistant-glass-market?vs Fire Resistant Glass Market Overview &
Rising Demand for Advanced Treatments to Propel Obliterative Bronchiolitis Market at 5.10% CAGR
Rising Demand for Advanced Treatments to Propel Obliterative Bronchiolitis Marke …
The Obliterative Bronchiolitis Market is undergoing a significant transformation, with industry forecasts predicting rapid expansion and cutting-edge technological innovations by 2032. As businesses continue to embrace digital advancements and strategic shifts, the sector is set to experience unprecedented growth, driven by rising demand, market expansion, and evolving industry trends. A recent in-depth market analysis sheds light on key factors propelling the Obliterative Bronchiolitis market forward, including increasing market share, dynamic segmentation,
Medical-Social Working Services Market Industry Trends and Forecast to 2030
Medical-Social Working Services Market Industry Trends and Forecast to 2030
This Medical-Social Working Services Market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and
Global Marine Insurance Market to Grow at 4.50% CAGR, Reaching USD 39.87 Billion by 2029
Global Marine Insurance Market to Grow at 4.50% CAGR, Reaching USD 39.87 Billion …
The Marine Insurance Market is undergoing a significant transformation, with industry forecasts predicting rapid expansion and cutting-edge technological innovations by 2032. As businesses continue to embrace digital advancements and strategic shifts, the sector is set to experience unprecedented growth, driven by rising demand, market expansion, and evolving industry trends. A recent in-depth market analysis sheds light on key factors propelling the Marine Insurance market forward, including increasing market share, dynamic segmentation,

All 5 Releases


More Releases for Kaposi

Kaposi Sarcoma Market forecast period 2023-2020
This Kaposi Sarcoma Market sector is rapidly evolving, with substantial growth and advancements expected by 2031. In-depth market research offers a comprehensive analysis of market size, share, and trends, providing crucial insights into its expansion. The report explores market segmentation and definitions, elucidating key components and drivers. Utilizing SWOT and PESTEL analyses, it evaluates the market's strengths, weaknesses, opportunities, and threats, as well as political, economic, social, technological, environmental, and legal factors.
Kaposi Sarcoma Market : Current Trends & Opportunities by 2024
The global market for Kaposi sarcoma is highly consolidated in nature with two players holding a massive share of the market, states a new market intelligence study that’s has been recently published by Transparency Market Research. In 2015, the two leading players, namely Merck & Co. Inc. and Johnson & Johnson held a share of around 50% of the global market and is projected to remain in the similar situation
Kaposi Sarcoma Treatment Market Drivers
Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma
Kaposi Sarcoma Market Research Report Forecast to 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of
Kaposi Sarcoma Market Research Report 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of
04-04-2017 | Health & Medicine
TMR
Kaposi Sarcoma Market: Patent Expiry of Blockbuster Drugs for Treatment of Kapos …
Kaposi sarcoma is a soft tissue sarcoma that develops in connective tissues, blood vessels, fibrous tissues, and muscles. It is a malignant, multi-centric, neoplastic vascular proliferation, characterized by the development of bluish-red cutaneous nodules on the feet. According to the U.S. Center for Disease Control and Prevention (CDC), Kaposi sarcoma is considered an acquired immune deficiency syndrome (AIDS) defining disease. This report analyzes the current and future prospects of the